Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update

Go back to Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update

Forte Biosciences (FBRX) Misses Q3 EPS by 2c

November 14, 2022 4:28 PM EST

Forte Biosciences (NASDAQ: FBRX) reported Q3 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

... More